Citations

Mayo Clinic

Showing 10 of 108523 citations.

A Case ofScopulariopsis brevicaulisEndocarditis with Mycotic Aneurysm in an Immunocompetent Host
Burgess, Mary Jo , Cawcutt, Kelly , Cawcutt, Kelly , Baddour, Larry M.

Case Reports in Medicine | March 17, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-4

10.1155/2015/872871 | PMID 25866512 Get It

Scopulariopsisis a genus of mold that is usually associated with onychomycosis and rarely causes complicated infection in immunocompetent persons. We describe a case of an immunocompetent 65-year-old male with a history of mitral valve repair with prosthetic ring placement who developed acute left posterior knee pain. Imaging showed a left popliteal artery aneurysm and thrombus, and further evaluation with transesophageal echocardiogram demonstrated two large, mobile mitral valve vegetations. He underwent debridement and replacement of the mitral valve, followed by debridement of the left popliteal artery with peroneal artery bypass. The intraoperative cultures grewScopulariopsis brevicaulis. Due to the resistant nature of the organism, he was initially treated with combination antifungals including liposomal amphotericin B, caspofungin, and voriconazole and was continued on chronic suppression with posaconazole with no evidence of recurrence.Scopulariopsisis a rare cause of fungal endocarditis. Treatment ofScopulariopsisendocarditis is challenging and is not well understood due to its rarity.
Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome – author's reply
Czaja, Albert J.

Alimentary Pharmacology & Therapeutics | March 17, 2015 | Volume: 41 | Issue: 8 | Pages: 794-795

10.1111/apt.13126 | PMID 25781048 Get It

Diffuse Vesicular Rash With Intractable Pruritus
Olson, Meredith A., Wieland, Carilyn N. , Newman, Catherine C.

JAMA | March 17, 2015 | Volume: 313 | Issue: 11 | Pages: 1158

10.1001/jama.2014.17575 | PMID 25781446 Get It

Patient characteristics associated with the level of patient‐reported care coordination among male patients with colorectal cancer in the Veterans Affairs health care system
Jackson, George L., Zullig, Leah L. , Provenzale, Dawn, Clauser, Steven B., Jindal, Rahul M. , Ryn, Michelle van , Phelan, Sean M. , Griffin, Joan M. , van Ryn, Michelle, Haggstrom, David Andrew , van Ryn, Michelle

Cancer | March 17, 2015 | Volume: 121 | Issue: 13 | Pages: 2207-2213

10.1002/cncr.29341 | PMID 25782082 Get It

BACKGROUNDThe current study was performed to determine whether patient characteristics, including race/ethnicity, were associated with patient‐reported care coordination for patients with colorectal cancer (CRC) who were treated in the Veterans Affairs (VA) health care system, with the goal of better understanding potential goals of quality improvement efforts aimed at improving coordination.METHODSThe nationwide Cancer Care Assessment and Responsive Evaluation Studies survey involved VA patients with CRC who were diagnosed in 2008 (response rate, 67%). The survey included a 4‐item scale of patient‐reported frequency (“never,” “sometimes,” “usually,” and “always”) of care coordination activities (scale score range, 1‐4). Among 913 patients with CRC who provided information regarding care coordination, demographics, and symptoms, multivariable logistic regression was used to examine odds of patients reporting optimal care coordination.RESULTSVA patients with CRC were found to report high levels of care coordination (mean scale score, 3.50 [standard deviation, 0.61]). Approximately 85% of patients reported a high level of coordination, including the 43% reporting optimal/highest‐level coordination. There was no difference observed in the odds of reporting optimal coordination by race/ethnicity. Patients with early‐stage disease (odds ratio [OR], 0.60; 95% confidence interval [95% CI], 0.45‐0.81), greater pain (OR, 0.97 for a 1‐point increase in pain scale; 95% CI, 0.96‐0.99), and greater levels of depression (OR, 0.97 for a 1‐point increase in depression scale; 95% CI, 0.96‐0.99) were less likely to report optimal coordination.CONCLUSIONSPatients with CRC in the VA reported high levels of care coordination. Unlike what has been reported in settings outside the VA, there appears to be no racial/ethnic disparity in reported coordination. However, challenges remain in ensuring coordination of care for patients with less advanced disease and a high symptom burden. Cancer 2015;121:2207–2213. © 2015 American Cancer Society.
Personalized Assessment and Management of Women at Risk for Breast Cancer in North America
Pruthi, Sandhya , Heisey, Ruth, Bevers, Therese B.

Women's Health | March 17, 2015 | Volume: 11 | Issue: 2 | Pages: 213-224

10.2217/whe.14.79 | PMID 25776295 Get It

Many women at increased risk for breast cancer would benefit from referral for genetic testing, enhanced screening, preventive therapy or risk-reducing surgery. We present a visual model and a step-wise approach to assist with a personalized risk stratification and management of these women. We present current recommendations with respect to lifestyle behaviors and mammographic screening, and we review the current evidence regarding enhanced screening and risk-reducing therapies. We discuss the usefulness of three risk-assessment tools in determining whether a woman qualifies for genetic testing, enhanced screening or preventive therapy and present four cases to demonstrate the usefulness of this approach in the clinical setting.
Women-Specific Factors to Consider in Risk, Diagnosis and Treatment of Cardiovascular Disease
Harvey, Ronée E. , Coffman, Kirsten E. , Miller, Virginia M. , Harvey, Ronée E

Women's Health | March 17, 2015 | Volume: 11 | Issue: 2 | Pages: 239-257

10.2217/whe.14.64 | PMID 25776297 Get It

In the era of individualized medicine, gaps in knowledge remain about sex-specific risk factors, diagnostic and treatment options that might reduce mortality from cardiovascular disease (CVD) and improve outcomes for both women and men. In this review, contributions of biological mechanisms involving the sex chromosomes and the sex hormones on the cardiovascular system will be discussed in relationship to the female-specific risk factors for CVD: hypertensive disorders of pregnancy, menopause and use of hormonal therapies for contraception and menopausal symptoms. Additionally, sex-specific factors to consider in the differential diagnosis and treatment of four prevalent CVDs (hypertension, stroke, coronary artery disease and congestive heart failure) will be reviewed with emphasis on areas where additional research is needed.
Association Between Thyrotropin Levels and Insulin Sensitivity in Euthyroid Obese Adolescents
Javed, Asma , Balagopal, Prabhakaran , Piccinini, Francesca, Man, Chiara Dalla , Giesler, Paula D., Laugen, Jeanette M., Kumar, Seema , Vella, Adrian , Fischer, Philip R. , Cobelli, Claudio , Dalla Man, Chiara

Thyroid® | March 17, 2015 | Volume: 25 | Issue: 5 | Pages: 478-484

10.1089/thy.2015.0005 | PMID 25777801 Get It

Background: Thyrotropin (TSH) levels display a positive association with body mass index (BMI), and the prevalence of isolated hyperthyrotropinemia is higher in obese adolescents compared to their normal weight controls. However, the metabolic significance of the higher TSH in obese adolescents is less clear. The objective of this study was to determine the relationship between TSH concentrations and insulin sensitivity, lipids, and adipokines in euthyroid, non-diabetic, obese adolescents. Methods: Thirty-six euthyroid, non-diabetic, obese adolescents between the ages of 12 and 18 years underwent a 75 g oral glucose tolerance test. Insulin sensitivity (S i ) and pancreatic β-cell function as assessed by disposition index (DI) were measured using the oral glucose minimal model approach. Cholesterol (total, low-density lipoprotein [LDL-C], and high-density lipoprotein [HDL-C]), triglycerides (TG), interleukin-6 (IL-6), total and high molecular weight (HMW) adiponectin, and retinol binding protein-4 (RBP4) were also determined. Associations between measures of thyroid function and S i , DI, lipids, and adipokines were computed using Pearson's correlation coefficient and multiple regression analysis. Results: The mean age of the subjects was 14.3±1.88 years, and the mean BMI was 32.5±4.65 kg/m 2 ; 97% were non-Hispanic white and 47% were male. The mean TSH was 2.7±1.2 mIU/L. Increasing serum TSH was correlated with decreasing S i (log S i ) in the entire cohort ( p =0.03), but this relationship persisted only in males ( p =0.02). The correlation between TSH and S i in males remained significant after adjusting for BMI ( p =0.02). There was no correlation between TSH and pancreatic β-cell function as assessed by DI ( p =0.48). TSH correlated positively with LDL-C ( p =0.04) and IL-6 ( p =0.03), but these associations vanished or weakened after adjusting for BMI (LDL-C p- value=0.44; IL-6 p- value=0.07). Conclusions: This study suggests a sex-specific association between TSH and insulin sensitivity in euthyroid, non-diabetic, obese adolescent males. Prospective studies are warranted to explore further this sexual dimorphism in the relationship between thyroid function and insulin sensitivity and to determine if obese adolescents with insulin resistance receiving thyroid supplements for hypothyroidism would benefit from targeting TSH levels in the lower half of normal range.
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation
Chaiteerakij, Roongruedee , Zhang, Xiaodan , Addissie, Benyam D., Harmsen, William S. , Theobald, Paul J., Peters, Brian E., Balsanek, Joseph G., Ward, Melissa M., Giama, Nasra H., Moser, Catherine D., Oseini, Abdul M., Umeda, Naoki, Venkatesh, Sudhakar K. , Harnois, Denise M. , Satomura, Shinji , Snyder, Melissa R. , Therneau, Terry M. , Roberts, Lewis R. , Chaiteerakij, Roongruedee , Mohamed, Essa A. , Charlton, Michael , Yamada, Hiroyuki , Algeciras‐Schimnich, Alicia , Roberts, Lewis R , Venkatesh, Sudhakar K

Liver Transplantation | March 17, 2015 | Volume: 21 | Issue: 5 | Pages: 599-606

10.1002/lt.24117 | PMID 25789635 Get It

Growing evidence suggests that pretransplant alpha‐fetoprotein (AFP) predicts outcomes of hepatocellular carcinoma (HCC) patients treated with liver transplantation. We aimed to determine whether pretransplant AFP, Lens culinaris agglutinin‐reactive alpha‐fetoprotein (AFP‐L3), and des‐gamma‐carboxyprothrombin (DCP) predicted HCC recurrence after transplantation. A retrospective cohort study of 313 HCC patients undergoing transplantation between 2000 and 2008 was conducted, and 48 (15.3%) developed recurrence during a median follow‐up of 90.8 months. The 127 patients with available serum drawn before transplantation were included; they included 86 without recurrence and 41 with recurrence. Serum was tested for AFP, AFP‐L3%, and DCP in a blinded fashion with the μTASWako i30 immunoanalyzer. All biomarkers were significantly associated with HCC recurrence. The hazard ratios (HRs) were 3.5 [95% confidence interval (CI), 1.9‐6.7; P < 0.0001] for DCP ≥ 7.5 ng/mL and 2.8 (95% CI, 1.4‐5.4; P = 0.002) for AFP ≥ 250 ng/mL. The HR increased to 5.2 (95% CI, 2.3‐12.0; P < 0.0001) when AFP ≥ 250 ng/mL and DCP ≥7.5 ng/mL were considered together. When they were combined with the Milan criteria, the HR increased from 2.6 (95% CI, 1.4‐4.7; P = 0.003) for outside the Milan criteria to 8.6 (95% CI, 3.0‐24.6; P < 0.0001) for outside the Milan criteria and AFP ≥ 250 ng/mL and to 7.2 (95% CI, 2.8‐18.1; P < 0.0001) for outside the Milan criteria and DCP ≥7.5 ng/mL. Our findings suggest that biomarkers are useful for predicting the risk of HCC recurrence after transplantation. Using both biomarkers and the Milan criteria may be better than using the Milan criteria alone in optimizing the decision of liver transplantation eligibility. Liver Transpl 21:599–606, 2015. © 2015 AASLD.
Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, Clare L. , Swisher, Elizabeth M. , Kaufmann, Scott H. , Kaufmann, Scott H , Swisher, Elizabeth M , Scott, Clare L

Journal of Clinical Oncology | March 17, 2015 | Volume: 33 | Issue: 12 | Pages: 1397-1406

10.1200/jco.2014.58.8848 | PMID 25779564 Get It

Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising activity in epithelial ovarian cancers, especially relapsed platinum-sensitive high-grade serous disease. Consistent with preclinical studies, ovarian cancers and a number of other solid tumor types occurring in patients with deleterious germline mutations in BRCA1 or BRCA2 seem to be particularly sensitive. However, it is also becoming clear that germline BRCA1/2 mutations are neither necessary nor sufficient for patients to derive benefit from PARP inhibitors. We provide an update on PARP inhibitor clinical development, describe recent advances in our understanding of PARP inhibitor mechanism of action, and discuss current issues in the development of these agents.